English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Results ONS was used in a total of 43 patients due to therapyresistant migraine (age 44.98 ± 10.6 years, range 22-69 years, 36 women, 7 men). Migraine had before existed an average of 28.47 ± 11.5 years. When starting treatment, the average MIDAS score was 129.14 ± 58.73, after one year it dropped to 87.44 ± 45.69 (p < 0.001). In the followup studies during the time of analysis, patients were asked whether they would choose to be treated with ONS again (answers: yes/ambivalent/no). In the follow up studies 1-6, the following answers were found: (1) 56.1/41.5/2.4; (2) 56.8/32.4/10.8; (3) 51.9/44.4/3.7; (4) 55.6/44.4/0; (5) 58.3/ 41.7/0; (6) 60.0/20.0/0. Conclusion ONS led to a positive evaluation in more than half of patients treated, despite therapy-resistance beforehand. The burden of chronic migraine can be significantly lifted through ONS. Only a very small fraction of patients would not choose this therapy again.

EHMTI-0389. Occipital nerve stimulation in the treatment of chronic migraine: experiences of two years